GSK618334
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK618334, covering 2017-06-22 to 2017-07-07. Get the full timeline:
Most recent: Clinical Trial Update: An Open Label Positron Emission Tomography (PET) Study of GSK618334 in Healthy Male Subjects Using 11C-PHNO as PET Ligand [Phase 1]